• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.

作者信息

Djamali Arjang, Muth Brenda L, Torrealba Jose, Bloom Debra, Miller Karen M, Lorentzen David, Sollinger Hans W, Pirsch John D, Mezrich Joshua D

机构信息

Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin, USA.

出版信息

Clin Transpl. 2009:485-90.

PMID:20524320
Abstract
摘要

相似文献

1
Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.硼替佐米作为肾移植后超急性和多药耐药混合性急性排斥反应的挽救疗法。
Clin Transpl. 2009:485-90.
2
Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report.蛋白酶体抑制剂用于早期抗体介导性排斥反应的挽救治疗：一例报告
Clin Transpl. 2009:461-3.
3
Bortezomib-based treatment of antibody mediated rejection in pancreas allograft recipients.基于硼替佐米治疗胰腺移植受者抗体介导的排斥反应
Clin Transpl. 2009:443-53.
4
The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation.硼替佐米抑制蛋白酶体在单纯肾脏或联合器官移植后抗体介导排斥反应治疗中的作用。
Transplantation. 2010 Dec 27;90(12):1486-92. doi: 10.1097/TP.0b013e3181fdd9b0.
5
Bortezomib rescue in refractory acute humoral rejection--report of a case.硼替佐米用于挽救难治性急性体液排斥反应——一例报告
Clin Transpl. 2009:431-2.
6
Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line?
Clin Transpl. 2009:425-9.
7
Bortezomib in the treatment of antibody-mediated rejection--a report of 3 cases.硼替佐米治疗抗体介导的排斥反应——3例报告
Clin Transpl. 2009:361-8.
8
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.硼替佐米为抗体介导和细胞介导的急性排斥反应提供了有效的治疗方法。
Transplantation. 2008 Dec 27;86(12):1754-61. doi: 10.1097/TP.0b013e318190af83.
9
Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.基于蛋白酶体抑制剂的原发性抗体介导的肾移植排斥反应治疗。
Transplantation. 2010 Feb 15;89(3):277-84. doi: 10.1097/TP.0b013e3181c6ff8d.
10
Use of bortezomib for prevention and treatment of rejection in sensitized patients.硼替佐米用于预防和治疗致敏患者的排斥反应。
Clin Transpl. 2009:499-503.

引用本文的文献

1
Novel Flow Cytometry Method Detecting Complement C1q Bound to Blood Type A/B IgG Antibody for Preventing Severe Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.新型流式细胞术检测与 A/B 血型 IgG 抗体结合的补体 C1q 用于预防 ABO 血型不相容肾移植中严重抗体介导的排斥反应
Antibodies (Basel). 2024 Aug 1;13(3):62. doi: 10.3390/antib13030062.
2
Refill-Based Medication Use Quality Measures in Kidney Transplant Recipients: Examination of Proportion of Days Covered and Medication Possession Ratio.基于续方的肾移植受者用药质量指标：覆盖天数比例和用药依从率的考察。
J Manag Care Spec Pharm. 2018 Apr;24(4):367-372. doi: 10.18553/jmcp.2018.24.4.367.
3
Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients.
在轻度至中度致敏的肾移植受者中，再灌注后活检中 C4d 增加和移植后一周供体特异性抗体增加是急性排斥反应的危险因素。
Kidney Int. 2013 Jun;83(6):1185-92. doi: 10.1038/ki.2013.44. Epub 2013 Feb 27.